Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

Research Institute of the McGill University Health Centre

$7,500.00

Aspirin for prevention of adverse pregnancy outcomes in systemic lupus erythematosus

FY 2015-16

Summary
Lupus is an auto-immune disease, which mostly affects women, can involve almost any organ, and has a tendency to flare during pregnancy. Until about 20 years ago, many young women with lupus were often recommended to avoid pregnancy because of the potential for complications. However, with modern management, currently many women with lupus can attempt to have babies, albeit with close monitoring and appropriate medications. Yet, in women with lupus, the risk of pregnancy complications is much higher than in healthy women. Low-dose aspirin ("baby aspirin") has shown a good effect in reducing the risk of certain pregnancy complications in women at high risk. However, to date, no study has evaluated the use of aspirin to prevent adverse pregnancy complications in a group composed solely of women with lupus. Thus, through the current application, our team is requesting funds to support activities to discuss the potential benefits of aspirin in lupus pregnancies and plan a study on the use of aspirin for prevention of pregnancy complications in women with lupus.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
334735
Name
Vinet Evelyne
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Planning and Dissemination - IMHA
Projecttitle
Aspirin for prevention of adverse pregnancy outcomes in systemic lupus erythematosus
Programtype2
Miscellaneous Programs
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$7,500
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Outcome Research; Pregnancy; Systemic Lupus Erythematosus
Abstract
Lupus is an auto-immune disease, which mostly affects women, can involve almost any organ, and has a tendency to flare during pregnancy. Until about 20 years ago, many young women with lupus were often recommended to avoid pregnancy because of the potential for complications. However, with modern management, currently many women with lupus can attempt to have babies, albeit with close monitoring and appropriate medications. Yet, in women with lupus, the risk of pregnancy complications is much higher than in healthy women. Low-dose aspirin ("baby aspirin") has shown a good effect in reducing the risk of certain pregnancy complications in women at high risk. However, to date, no study has evaluated the use of aspirin to prevent adverse pregnancy complications in a group composed solely of women with lupus. Thus, through the current application, our team is requesting funds to support activities to discuss the potential benefits of aspirin in lupus pregnancies and plan a study on the use of aspirin for prevention of pregnancy complications in women with lupus.
Competitiondate
201508
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vinet, Evelyne; Bernatsky, Sasha R
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $7,500~ $0~